GLOW vs NAD+: What Is the Difference?
A skin-research peptide blend against a coenzyme that is not a peptide at all — and comes in vials fifty times larger.
In plain English
GLOW is a 70 mg vial of GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg, studied together in skin and connective-tissue research.
NAD+ is a coenzyme, not a peptide — a small helper molecule present in every living cell and central to converting food into usable energy.
The difference, without the jargon
These belong to different chemical categories entirely, which shows up immediately in how they are handled. NAD+ is not made of amino acids and does not behave like something that is. It comes in 500 mg vials because chemical reactions consume it in bulk. It pulls moisture out of the air so aggressively that opening a cold vial condenses water onto the contents, which both starts degrading it and makes weighing unreliable. And it is destroyed by alkaline conditions. GLOW is a peptide mixture whose main handling considerations are the ordinary ones — refrigeration, light protection, and the blend-specific requirement that a lab report identify each ingredient with a ratio rather than reporting one overall number.
Common questions
Is NAD+ a peptide like the ingredients in GLOW?
No. NAD+ is a coenzyme built from nucleotides, not amino acids, and it shares almost no chemistry with peptides. It appears alongside them because of shared research interest in cellular biology, not because it is related.
Why is the NAD+ vial so much bigger?
Because it is consumed in bulk by chemical reactions rather than acting as a signal at low levels. That is why 500 mg vials are routine for it while peptides come in 5 to 20 mg.
What is the main storage difference?
NAD+ needs protection from moisture above all — letting the sealed vial warm to room temperature before opening is the key habit. Peptide blends mainly need refrigeration, light protection, and awareness that the shortest-lived ingredient sets the usable window.
Technical reference below
How they actually differ
Comparing the two: GLOW is three-component dermal research blend — ghk-cu 50 mg / bpc-157 10 mg / tb-500 10 mg (70 mg total), while NAD+ is dinucleotide coenzyme — not a peptide — different molecular classes with different handling consequences; they call for different primary diluents (bacteriostatic water (0.9% benzyl alcohol) versus sterile or bacteriostatic water); their leading degradation routes differ (copper dissociation from the ghk-cu component at acidic ph or on contact with chelators such as edta for GLOW, alkaline hydrolysis for NAD+), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
GLOW — origin
GLOW combines three of the most-studied compounds in tissue and dermal research into one 70 mg vial: GHK-Cu (50 mg), BPC-157 (10 mg) and TB-500 (10 mg). The rationale is mechanistic complementarity — GHK-Cu research centres on collagen and extracellular matrix synthesis, BPC-157 on angiogenesis and growth-factor signalling, and TB-500 on actin-mediated cell migration. Three non-overlapping routes into the same repair biology.
NAD+ — origin
NAD+ is not a peptide at all, and that single fact governs everything about how it is handled. It is a dinucleotide coenzyme — nicotinamide and adenine linked through a pyrophosphate bridge — present in every living cell and central to redox metabolism. It was first identified in 1906 by Arthur Harden as a small heat-stable factor required for yeast fermentation.
GLOW research themes
The majority component, with the deepest dermal literature — collagen and glycosaminoglycan synthesis in fibroblast models.
Studied around vessel formation and growth-factor pathways in tissue-repair models.
Actin sequestration and directed cell movement — how cells reach a tissue defect.
The three components act through genuinely non-overlapping mechanisms, which is the rationale for combining them.
NAD+ research themes
Sirtuins consume NAD+ as a co-substrate, which links cellular NAD+ availability directly to their activity.
Its canonical role as the central redox carrier of cellular respiration.
PARP enzymes consume NAD+ during DNA damage response, a heavily studied competing demand.
A major driver of current research interest: measured NAD+ levels fall with age across tissues in animal models.
GLOW handling
- Never reconstitute in acidic diluent — this dissociates copper from the GHK-Cu component, which is the majority of the vial.
- Keep chelating agents such as EDTA out of any buffer used with GLOW; they will strip the copper.
- Treat colour as data: clear, even blue is correct. Pale, colourless or green means the GHK-Cu component has degraded.
- Protect from light for the TB-500 and GHK-Cu components, and minimise headspace exposure.
- Do not subdivide the dry cake — three co-lyophilized components do not partition evenly in powder form.
NAD+ handling
- Allow the sealed vial to reach room temperature before opening — opening a cold vial of hygroscopic material condenses water directly onto it.
- Keep solutions at or below neutral pH; alkaline conditions destroy NAD+ quickly.
- Prepare fresh solutions where concentration accuracy is important rather than relying on stored stock.
- Protect from light at all stages.
Both third-party tested
Every Popular Peptides batch of GLOW and NAD+ is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
GLOW reference
Related comparisons
GLOW and NAD+ are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.